Koers Beleave Inc. Canadian Securities Exchange
Aandelen
BE
CA0775611084
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | 2,37 3,24 2,18 | Marktkapitalisatie | 30,37 mln. 41,39 mln. 27,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -12 mln. -16,36 mln. -11,04 mln. | Nettowinst (verlies) 2019 | -33 mln. -44,98 mln. -30,35 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 5,2 mln. 7,09 mln. 4,78 mln. | Nettoschuld 2019 | 10,32 mln. 14,06 mln. 9,49 mln. | EV/omzet 2019 | 17.137.012 x |
K/w-verhouding 2018 |
-4,72
x | K/w-verhouding 2019 |
-0,76
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 98,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 26-05-00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Founder | - | 26-05-00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,15% | 6,38 mld. | |
-14,00% | 4,59 mld. | |
+9,54% | 3,39 mld. | |
-8,99% | 3,2 mld. | |
-2,41% | 2,52 mld. | |
+50,03% | 2 mld. | |
-6,97% | 1,7 mld. | |
-0,31% | 1,65 mld. | |
-10,61% | 1,58 mld. |